0001578563-24-000186.txt : 20240409
0001578563-24-000186.hdr.sgml : 20240409
20240409165814
ACCESSION NUMBER: 0001578563-24-000186
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20240409
DATE AS OF CHANGE: 20240409
EFFECTIVENESS DATE: 20240409
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Avalo Therapeutics, Inc.
CENTRAL INDEX KEY: 0001534120
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 450705648
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-510110
FILM NUMBER: 24833374
BUSINESS ADDRESS:
STREET 1: 540 GAITHER ROAD
STREET 2: SUITE 400
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
BUSINESS PHONE: 410-522-8707
MAIL ADDRESS:
STREET 1: 540 GAITHER ROAD
STREET 2: SUITE 400
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
FORMER COMPANY:
FORMER CONFORMED NAME: Cerecor Inc.
DATE OF NAME CHANGE: 20111102
D
1
primary_doc.xml
X0708
D
LIVE
0001534120
Avalo Therapeutics, Inc.
540 GAITHER ROAD
SUITE 400
ROCKVILLE
MD
MARYLAND
20850
410-522-8707
DELAWARE
Cerecor Inc.
Corporation
true
Garry
Neil, M.D.
c/o Avalo Therapeutics, Inc.
540 Gaither Road, Suite 400
Rockville
MD
MARYLAND
20850
Executive Officer
Director
June
Almenoff, M.D., Ph.D.
c/o Avalo Therapeutics, Inc.
540 Gaither Road, Suite 400
Rockville
MD
MARYLAND
20850
Director
Mitchell
Chan
c/o Avalo Therapeutics, Inc.
540 Gaither Road, Suite 400
Rockville
MD
MARYLAND
20850
Director
Jonathan
Goldman, M.D.
c/o Avalo Therapeutics, Inc.
540 Gaither Road, Suite 400
Rockville
MD
MARYLAND
20850
Director
Aaron
Kantoff
c/o Avalo Therapeutics, Inc.
540 Gaither Road, Suite 400
Rockville
MD
MARYLAND
20850
Director
Gilla
Kaplan, Ph.D.
c/o Avalo Therapeutics, Inc.
540 Gaither Road, Suite 400
Rockville
MD
MARYLAND
20850
Director
Magnus
Persson, M.D., Ph.D.
c/o Avalo Therapeutics, Inc.
540 Gaither Road, Suite 400
Rockville
MD
MARYLAND
20850
Director
Samantha
Truex
c/o Avalo Therapeutics, Inc.
540 Gaither Road, Suite 400
Rockville
MD
MARYLAND
20850
Director
Christopher
Sullivan
c/o Avalo Therapeutics, Inc.
540 Gaither Road, Suite 400
Rockville
MD
MARYLAND
20850
Executive Officer
Biotechnology
Decline to Disclose
- 06b
false
2024-03-27
false
true
true
true
The offering is made in connection with the merger of Project Athens Merger Sub, Inc. into AlmataBio, Inc. and AlmataBio, Inc. into Second Project Athens Merger Sub, LLC, pursuant to an Agreement and Plan of Merger and Reorganization dated March 27, 2024.
0
Oppenheimer & Co. Inc.
249
None
None
85 Broad Street
4th Floor
New York
NY
NEW YORK
10004
All States
false
199976986
130601986
69375000
The Total Remaining to be Sold represents warrants issued at closing that have not yet been exercised.
false
25
0
6937500
0
Other than the payment of salaries and other compensation and reimbursement of expenses, no officer, director, partner, manager or promoter will receive any payments from the proceeds of this offering.
false
Avalo Therapeutics, Inc.
/s/ Garry A. Neil
Garry A. Neil
Chief Executive Officer
2024-04-09